The real acceleration came in April after the FDA granted fast-track status to one of the firm's drugs that helps treat respiratory issues in COVID-19 patients.
Now, the stock has since come back down to Earth, and is holding just below $3 a share.
But that could soon change…
Because Monday, the company issued a press release announcing a live webcast tomorrow, Thursday November 5 to provide an update on its clinical and regulatory developments.
Now, good news is never a guarantee.
But at least two insiders are betting on it…
Including the company's general counsel who just picked up 10,000 shares, along with another director who dumped nearly $300k into the stock.
You can follow their lead and get in, too…
But time is of the essence if you want to capitalize on tomorrow's potential pop.
So if you'd like to learn more about Ross' methodology for tracking insider activity and following their lead to major profits…
AND find out how you can get your hands on this ticker symbol today…
Just click here to view a no-cost training video that will walk you through it step by step!
Yours for massive trading success,
No comments:
Post a Comment